WO2016082807A3 - 伊曲康唑的新用途 - Google Patents

伊曲康唑的新用途 Download PDF

Info

Publication number
WO2016082807A3
WO2016082807A3 PCT/CN2016/072425 CN2016072425W WO2016082807A3 WO 2016082807 A3 WO2016082807 A3 WO 2016082807A3 CN 2016072425 W CN2016072425 W CN 2016072425W WO 2016082807 A3 WO2016082807 A3 WO 2016082807A3
Authority
WO
WIPO (PCT)
Prior art keywords
itraconazole
new use
new
hemangiomas
drug
Prior art date
Application number
PCT/CN2016/072425
Other languages
English (en)
French (fr)
Other versions
WO2016082807A2 (zh
Inventor
冉玉平
Original Assignee
四川大学华西医院
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 四川大学华西医院 filed Critical 四川大学华西医院
Publication of WO2016082807A2 publication Critical patent/WO2016082807A2/zh
Publication of WO2016082807A3 publication Critical patent/WO2016082807A3/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

本发明提供了伊曲康唑在制备治疗血管瘤的药物中的用途。
PCT/CN2016/072425 2014-11-28 2016-01-28 伊曲康唑的新用途 WO2016082807A2 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201410707593 2014-11-28
CN201410707593.5 2014-11-28

Publications (2)

Publication Number Publication Date
WO2016082807A2 WO2016082807A2 (zh) 2016-06-02
WO2016082807A3 true WO2016082807A3 (zh) 2016-07-21

Family

ID=56075085

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2016/072425 WO2016082807A2 (zh) 2014-11-28 2016-01-28 伊曲康唑的新用途

Country Status (2)

Country Link
CN (1) CN105640957B (zh)
WO (1) WO2016082807A2 (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111487398B (zh) * 2019-01-25 2022-11-11 四川大学华西医院 血管瘤治疗的生物标记物
CN110279696A (zh) * 2019-07-31 2019-09-27 中国医学科学院皮肤病医院 伊曲康唑在制备抑制肿瘤转移药物中的应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101711156A (zh) * 2007-04-05 2010-05-19 约翰·霍普金斯大学 作为血管新生抑制剂的伊曲康唑的手性纯的异构物及羊毛甾醇14a-去甲基酶的抑制剂

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101711156A (zh) * 2007-04-05 2010-05-19 约翰·霍普金斯大学 作为血管新生抑制剂的伊曲康唑的手性纯的异构物及羊毛甾醇14a-去甲基酶的抑制剂

Also Published As

Publication number Publication date
CN105640957B (zh) 2020-04-07
WO2016082807A2 (zh) 2016-06-02
CN105640957A (zh) 2016-06-08

Similar Documents

Publication Publication Date Title
IL272820B (en) The history of sulfamoylpyrrolamide and their use as drugs to treat jaundice b
EP3154594A4 (en) Fap-activated therapeutic agents, and uses related thereto
EP3170467A4 (en) Ultrasonic vibrator for medical treatment
IL254142B (en) Tredifitant for use in the treatment of a disease or medical condition that responds to Tredifitent
EP3188721A4 (en) Human therapeutic agents
IL252897A0 (en) Indanyl compounds, pharmaceutical preparations and their medical uses
EP2905006B8 (fr) Dispositif de discrimination des stades de sommeil d'un patient.
IL247969B (en) A medicinal component for use in the treatment of infections
WO2016082807A3 (zh) 伊曲康唑的新用途
HK1251476A1 (zh) 用於治療癌症的氨基硫羥酸酯化合物或其藥學上可接受的鹽
EP3145525A4 (en) Use of microperoxidases for the treatment of carboxyhemoglobinemia
EP3479785A4 (en) MEDICAL TREATMENT DEVICE
EP3094330A4 (en) Treatment of crohn's disease using low doses of laquinimod
HRP20182167T1 (hr) Derivati benzilhidroksida, njihova priprava i njihova terapeutska uporaba
EP3579843A4 (en) 3-BETA-HYDROXY-5-ALPHA-PRÉGNAN-20-ONE FOR USE IN MEDICAL TREATMENT
AU2016902139A0 (en) New Therapeutic Treatment Combination
AU2014902075A0 (en) New Therapeutic Treatment Combination
AU2015902062A0 (en) New Therapeutic Treatment Combination

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16724838

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 16724838

Country of ref document: EP

Kind code of ref document: A2